Showing results (441-450 of 500) with videos related to
Sort By:
Pageof 50
Neuro-Oncology|July 22, 2025
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspectiveMartin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson, et al.The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practiceSpyridon Bakas, Philipp Vollmuth, Norbert Galldiks, et al.The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.Neuro-Oncology|December 10, 2024
Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER ConsortiumJasper K W Gerritsen, Philipp Karschnia, Jacob S Young, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.Acta Neuropathologica|September 6, 2020
The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paragangliomaBiswarathan Ramani, Rohit Gupta, Jasper Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.Oncotarget|December 10, 2015
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma riskKyle M Walsh, Veryan Codd, Terri Rice, et al.The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancementsJavier E Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, et al.Pageof 50